Health Carehttp://www.cnbc.com/id/10000108Mon, 03 Dec 2012 00:21 GMTMon, 03 Dec 2012 00:21 GMTen-us60Contraception & Religious Freedomhttp://video.cnbc.com/gallery/?play=1&video=3000145411Sat, 02 Feb 2013 00:15 GMTguid_100428605 Doctors, Insurers Trade Blame on Out-of-Network Feeshttp://www.cnbc.com/id/100427591Fri, 01 Feb 2013 18:57 GMTguid_100427591 Obama Offers Compromise on Birth Control Coveragehttp://www.cnbc.com/id/100427793Fri, 01 Feb 2013 18:41 GMTguid_100427793 Roche's CEO on Profit Pipelinehttp://video.cnbc.com/gallery/?play=1&video=3000144012Fri, 01 Feb 2013 12:31 GMTguid_100426580 UPDATE 4-Merck shares fall on worries about osteoporosis drughttp://www.cnbc.com/id/100427496Fri, 01 Feb 2013 05:23 GMTguid_100427496 Money In the 'Death Care' Industryhttp://video.cnbc.com/gallery/?play=1&video=3000145141Fri, 01 Feb 2013 00:55 GMTguid_100425464 Obamacare Buyer's Remorse?http://video.cnbc.com/gallery/?play=1&video=3000145064Fri, 01 Feb 2013 00:48 GMTguid_100425461 Boehringer Ingelheim Ohio subsidiary enters consent decreehttp://www.cnbc.com/id/100424567Thu, 31 Jan 2013 19:52 GMTguid_100424567 Business Buzz: Paul Jacobshttp://video.cnbc.com/gallery/?play=1&video=3000144882Thu, 31 Jan 2013 08:00 GMTguid_100422092 Obamacare Just Got Less Affordable for Millionshttp://www.cnbc.com/id/100422119Thu, 31 Jan 2013 05:00 GMTguid_100422119 UPDATE 1-Second Twitter hoax in two days smacks another stockhttp://www.cnbc.com/id/100420903Wed, 30 Jan 2013 20:43 GMTguid_100420903 Isis Pharma shares rise on Kynamro approvalhttp://www.cnbc.com/id/100420674Wed, 30 Jan 2013 19:05 GMTguid_100420674 UPDATE 2-Roche flags further growth as new drugs deliverhttp://www.cnbc.com/id/100418731Wed, 30 Jan 2013 09:28 GMTguid_100418731 Roche CEO: Emerging Markets Key to Momentumhttp://www.cnbc.com/id/100415904Wed, 30 Jan 2013 06:11 GMTguid_100415904 FDA gives new drug application approval to Isishttp://www.cnbc.com/id/100418012Wed, 30 Jan 2013 01:01 GMTguid_100418012 Beijing Shuts Factories as Smog Levels Surgehttp://www.cnbc.com/id/100417934Wed, 30 Jan 2013 00:06 GMTguid_100417934 Vertex swings to loss on weak hep C drug saleshttp://www.cnbc.com/id/100417931Tue, 29 Jan 2013 23:51 GMTguid_100417931 UPDATE 1-FDA approves Sanofi drug for rare cholesterol disorderhttp://www.cnbc.com/id/100417909Tue, 29 Jan 2013 23:38 GMTguid_100417909 FDA approves Sanofi drug for hereditary cholesterol disorderhttp://www.cnbc.com/id/100417885Tue, 29 Jan 2013 23:23 GMTguid_100417885 Keryx announces $55M public offeringhttp://www.cnbc.com/id/100417726Tue, 29 Jan 2013 22:29 GMTguid_100417726 WRAPUP 2-Pfizer, Lilly profits beat Street; generics take tollhttp://www.cnbc.com/id/100417573Tue, 29 Jan 2013 21:26 GMTguid_100417573 Keryx shares keep climbing on drug trial resultshttp://www.cnbc.com/id/100417289Tue, 29 Jan 2013 20:22 GMTguid_100417289 Eli Lilly Loses to Generics, but Beats Estimateshttp://www.cnbc.com/id/100415249Tue, 29 Jan 2013 12:19 GMTguid_100415249 UPDATE 1-Lilly loses ground in fourth quarter to genericshttp://www.cnbc.com/id/100415222Tue, 29 Jan 2013 11:58 GMTguid_100415222 Lilly fourth-quarter profit fall as generics hurt saleshttp://www.cnbc.com/id/100415126Tue, 29 Jan 2013 11:43 GMTguid_100415126 Opko Health CEO on Cytochromas Acquisitionhttp://video.cnbc.com/gallery/?play=1&video=3000144067Mon, 28 Jan 2013 23:15 GMTguid_100414044 Furiex jumps after diabetes drug approvalhttp://www.cnbc.com/id/100413239Mon, 28 Jan 2013 18:43 GMTguid_100413239 FDA accepts application for new Sanofi MS drughttp://www.cnbc.com/id/100412734Mon, 28 Jan 2013 16:17 GMTguid_100412734 Keryx shares soar on kidney drug resultshttp://www.cnbc.com/id/100412610Mon, 28 Jan 2013 15:50 GMTguid_100412610 UPDATE 2-Medical isotope maker Nordion explores alternativeshttp://www.cnbc.com/id/100412605Mon, 28 Jan 2013 15:48 GMTguid_100412605